Recent advances of chitosan formulations in biomedical applications

MAS Abourehab, S Pramanik, MA Abdelgawad… - International journal of …, 2022 - mdpi.com
Chitosan, a naturally abundant cationic polymer, is chemically composed of cellulose-based
biopolymers derived by deacetylating chitin. It offers several attractive characteristics such …

Biomedical application of chitosan-based nanoscale delivery systems: Potential usefulness in siRNA delivery for cancer therapy

M Ashrafizadeh, M Delfi, F Hashemi, A Zabolian… - Carbohydrate …, 2021 - Elsevier
Gene therapy is an emerging and promising strategy in cancer therapy where small
interfering RNA (siRNA) system has been deployed for down-regulation of targeted gene …

[HTML][HTML] Small interfering RNA for cancer treatment: overcoming hurdles in delivery

NB Charbe, ND Amnerkar, B Ramesh… - … Pharmaceutica Sinica B, 2020 - Elsevier
In many ways, cancer cells are different from healthy cells. A lot of tactical nano-based drug
delivery systems are based on the difference between cancer and healthy cells. Currently …

Chitosan as a machine for biomolecule delivery: A review

Z Mohammadi, M Eini, A Rastegari, MR Tehrani - Carbohydrate Polymers, 2021 - Elsevier
The major role of biomolecules in treatment of different diseases has been proven by
several studies. However, the main drawback in successful treatment by these molecules is …

Emerging trends in the nanomedicine applications of functionalized magnetic nanoparticles as novel therapies for acute and chronic diseases

S Dash, T Das, P Patel, PK Panda, M Suar… - Journal of …, 2022 - Springer
High-quality point-of-care is critical for timely decision of disease diagnosis and healthcare
management. In this regard, biosensors have revolutionized the field of rapid testing and …

Nanoparticles as theranostic vehicles in experimental and clinical applications—focus on prostate and breast cancer

J Elgqvist - International journal of molecular sciences, 2017 - mdpi.com
Prostate and breast cancer are the second most and most commonly diagnosed cancer in
men and women worldwide, respectively. The American Cancer Society estimates that …

Current advancements in self-assembling nanocarriers-based siRNA delivery for cancer therapy

G Kandasamy, D Maity - Colloids and Surfaces B: Biointerfaces, 2023 - Elsevier
Different therapeutic practices for treating cancers have significantly evolved to compensate
and/or overcome the failures in conventional methodologies. The demonstrated potentiality …

Combination of Nanovectorized siRNA Directed against Survivin with Doxorubicin for efficient anti-cancer activity in HER2+ breast Cancer cells

S Eljack, E Allard-Vannier, Y Misericordia… - Pharmaceutics, 2022 - mdpi.com
According to Globocan 2020, breast cancer is considered one of the most common cancers
affecting women and is one of the leading causes of death in over 100 countries. The …

Chitosan as possible inhibitory agents and delivery systems in leukemia

P Zivarpour, J Hallajzadeh, Z Asemi, F Sadoughi… - Cancer Cell …, 2021 - Springer
Leukemia is a lethal cancer in which white blood cells undergo proliferation and immature
white blood cells are seen in the bloodstream. Without diagnosis and management in early …

[PDF][PDF] Chitosan-functionalized bioplatforms and hydrogels in breast cancer: immunotherapy, phototherapy and clinical perspectives

T Li, M Ashrafizadeh, Y Shang, YN Ertas… - Drug Discovery …, 2024 - researchgate.net
The incidence rate of breast cancer in women is high, and this has caused a significant
health problem for society and public health providers.(p1) The epidemiological data …